scispace - formally typeset
H

Hiroshi Maeda

Researcher at Kumamoto University

Publications -  915
Citations -  67944

Hiroshi Maeda is an academic researcher from Kumamoto University. The author has contributed to research in topics: Neocarzinostatin & Nitric oxide. The author has an hindex of 103, co-authored 893 publications receiving 63370 citations. Previous affiliations of Hiroshi Maeda include Osaka University & Okayama University.

Papers
More filters
Journal ArticleDOI

Role of Nitric Oxide in Pathogenesis of Herpes Simplex Virus Encephalitis in Rats

TL;DR: High level of NO produced by iNOS is a pathogenic factor in HSV-1-induced encephalitis in rats, and treatment of virus-infected animals with the NOS inhibitor Nomega-monomethyl-l-arginine significantly ameliorated not only clinical symptoms such as paralysis and seizures but also mortality.
Journal ArticleDOI

Therapeutic effect of erythromycin on influenza virus-induced lung injury in mice

TL;DR: The results indicate that EM may have substantial therapeutic value for various acute inflammatory disorders such as influenza-virus-induced pneumonia, by inhibiting inflammatory-cell responses and suppressing NO overproduction in the lung.
Journal ArticleDOI

In Vivo Production of Nitric Oxide in Rats after Administration of Hydroxyurea

TL;DR: It is reported that the administration of hydroxyurea, an antitumor drug, to rats at pharmacological doses formed detectable nitrosyl hemoglobin, which increased with dose, which verified that nitric oxide detected as nitro SYL hemoglobin or nitroSyl hemoprotein complexes in rats was the result of the metabolism of hydroXYurea.
Journal ArticleDOI

Polymeric micelles of zinc protoporphyrin for tumor targeted delivery based on EPR effect and singlet oxygen generation

TL;DR: The synergistic effects of light induced photosensitizing capabilities and HO-1 inhibitory potentials of these unique micelles of ZnPP when tested in vitro and in vivo on tumor models under localized, mild illumination conditions using a tungsten–xenon light source indicate that they portend to be promising candidates for targeted chemotherapy as well as photodynamic therapy against superficial tumors aswell as solid tumors located at light penetrable depths.